Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL35739365 | 1.00 | FFAR4 (0.32) | FFAR4 | |
| SCHEMBL15695410 | 0.94 | FFAR4 (0.31) | FFAR4 | |
| SCHEMBL27006304 | 0.93 | DHODH (0.38) | FFAR4 | |
| SCHEMBL14926808 | 0.92 | FFAR4 (0.33) | FFAR4 | |
| SCHEMBL18310553 | 0.91 | FFAR4 (0.32) | FFAR4 | |
| SCHEMBL15695413 | 0.89 | — | — | |
| SCHEMBL15695411 | 0.89 | — | — | |
| SCHEMBL18030468 | 0.89 | FFAR4 (0.33) | FFAR4 | |
| SCHEMBL27006323 | 0.87 | — | — | |
| SCHEMBL17033228 | 0.87 | FFAR4 (0.32) | FFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022050164-A1 | LIQUID CRYSTAL COMPOSITION AND ACTUATOR USING SAME | ＥＮＥＯＳ株式会社 | 2022-03-10 | — | — | WO | disclosed |
| US-9738831-B2 | Optically isotropic liquid crystal composition and optical device | JNC CORPORATION (JP) | 2017-08-22 | — | — | US | disclosed |
| US-20170233653-A1 | LIQUID CRYSTAL DEVICE | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2017-08-17 | — | — | US | disclosed |
| US-20170233653-A1 | LIQUID CRYSTAL DEVICE | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2017-08-17 | — | — | US | disclosed |
| US-20150240159-A1 | OPTICALLY ISOTROPIC LIQUID CRYSTAL COMPOSITION AND OPTICAL DEVICE | JNC CORPORATION (JP) | 2015-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170233653-A1 | LIQUID CRYSTAL DEVICE | NCS1, NLK, HCN2 | FFAR4 4303/4885 |
| US-20150240159-A1 | OPTICALLY ISOTROPIC LIQUID CRYSTAL COMPOSITION AND OPTICAL DEVICE | SCO2, CNOT1, LEO1 | FFAR4 1818/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.